Antigenemia na vigilancia do CMV apos o dia +100 e infeccao tardia pelo CMV em TMO alogenico

Camila Maria Longo Machado(Universidade de São Paulo), Cláudio Mendes Pannuti, Jussara Bianchi Castelli, Frederico Luis Dulley(Federal Government of Brazil), Ana Verena Almeida Mendes(Escola Bahiana de Medicina e Saúde Pública), Lucy Santos Vilas Boas(Universidade de São Paulo), MCA Macedo

Revista da Sociedade Brasileira de Medicina Tropical

January 1, 2001

Cited by 2

Related Papers

Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK

|The Lancet|2020|5k

Single-dose administration and the influence of the timing of the booster dose on immunogenicity and efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine: a pooled analysis of four randomised trials

|The Lancet|2021|1.2k

Heterologous versus homologous COVID-19 booster vaccination in previous recipients of two doses of CoronaVac COVID-19 vaccine in Brazil (RHH-001): a phase 4, non-inferiority, single blind, randomised study

|The Lancet|2022|467

Genomic Evidence of SARS-CoV-2 Reinfection Involving E484K Spike Mutation, Brazil

|Emerging infectious diseases|2021|215

Efficacy of Brazilian green propolis (EPP-AF®) as an adjunct treatment for hospitalized COVID-19 patients: A randomized, controlled clinical trial

|Biomedicine & Pharmacotherapy|2021|121